Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia. Ballantyne CM, Gaudet D, Rosenson RS, Hegele RA, et al. J Am Coll Cardiol 2025;85:1839-1854.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ballantyne CM, Gaudet D, Rosenson RS, Hegele RA, et al. Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia. J Am Coll Cardiol 2025;85:1839-1854.
PMID: 40099777